Haney A F
Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, N.C. 27710.
Prog Clin Biol Res. 1990;323:1-14.
Based on the available scientific evidence, the mechanism of developing endometriosis appears to be transplantation of viable endometrial cell fragments shed during menses and regurgitated through the fallopian tubes under the influence of prostaglandin-mediated uterine contractions. As all women apparently retrograde menstruate to some extent, it is not surprising that circumstances which increase the total number of menstrual days experienced have been clinically associated with endometriosis. Similarly, factors which lead to relative uterine outflow obstruction have been associated with a higher incidence of endometriosis. There is virtually no other scientific evidence supporting alternate mechanisms of development of endometriosis. There are many unanswered questions regarding endometriosis including: 1) Are all women equally susceptible to development of the disease? 2) As the clinical presentation and course is extremely variable, what factors influence these events? 3) Does medical suppression of ovulation with oral contraceptives or continuous progestins provide a protective effect? 4) Are there systemic immunologic changes associated with endometriosis? Hopefully, this manuscript will help stimulate the next generation of clinical investigators to address these questions, as they are of paramount importance with this apparently increasingly devastating and frequent clinical disease.
基于现有的科学证据,子宫内膜异位症的发病机制似乎是在月经期间脱落的有活力的子宫内膜细胞碎片,在前列腺素介导的子宫收缩影响下通过输卵管反流而发生移植。由于显然所有女性在某种程度上都会发生逆行月经,因此临床上,月经天数增加的情况与子宫内膜异位症相关也就不足为奇了。同样,导致相对子宫流出道梗阻的因素也与子宫内膜异位症的较高发病率相关。实际上,几乎没有其他科学证据支持子宫内膜异位症的其他发病机制。关于子宫内膜异位症有许多未解决的问题,包括:1)所有女性对该疾病的易感性是否相同?2)由于临床表现和病程差异极大,哪些因素会影响这些情况?3)口服避孕药或持续使用孕激素进行药物性抑制排卵是否具有保护作用?4)是否存在与子宫内膜异位症相关的全身免疫变化?希望这篇文章能有助于激励下一代临床研究人员解决这些问题,因为对于这种明显日益严重且常见的临床疾病来说,这些问题至关重要。